BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jadaon MM. Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region. Mediterr J Hematol Infect Dis 2011;3:e2011037. [PMID: 22224194 DOI: 10.4084/MJHID.2011.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Rezus E, Tamba BI, Badescu MC, Popescu D, Bratoiu I, Rezus C. Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications. Int J Mol Sci 2021;22:6801. [PMID: 34202897 DOI: 10.3390/ijms22136801] [Reference Citation Analysis]
2 Sivadas A, Scaria V. Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences. Pharmacogenomics J 2018;18:590-600. [PMID: 29720721 DOI: 10.1038/s41397-018-0022-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Hotoleanu C. Genetic Risk Factors in Venous Thromboembolism. Adv Exp Med Biol 2017;906:253-72. [PMID: 27638626 DOI: 10.1007/5584_2016_120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
4 Ezzat H, Attia FA, Mokhtar A, El-tokhy HM, Alalfy MN, Elkhouly NY. Prevalence of thrombophilic gene polymorphisms (FVL G1691A and MTHFR C677T) in patients with myocardial infarction. Egyptian Journal of Medical Human Genetics 2014;15:113-23. [DOI: 10.1016/j.ejmhg.2014.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
5 Al-Allawi NA, Badi AI, Goran MA, Nerweyi FF, Ballo HM, Al-Mzury NT. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients. Genet Test Mol Biomarkers 2015;19:500-4. [PMID: 26196588 DOI: 10.1089/gtmb.2015.0099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Chamorro AJ, Marcos M, Hernández-García I, Calvo A, Mejia JC, Cervera R, Espinosa G. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis. Autoimmun Rev 2013;12:607-16. [PMID: 23207285 DOI: 10.1016/j.autrev.2012.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
7 Moussaoui S, Saussoy P, Ambroise J, Defour JP, Zouitene R, Sifi K, Abadi N. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population. Clin Appl Thromb Hemost 2017;23:105-15. [DOI: 10.1177/1076029615600789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Zhang P, Zhang J, Sun G, Gao X, Wang H, Yan W, Xu H, Zu M, Ma H, Wang W, Lu Z. Risk of Budd-Chiari syndrome associated with factor V Leiden and G20210A prothrombin mutation: a meta-analysis. PLoS One 2014;9:e95719. [PMID: 24755609 DOI: 10.1371/journal.pone.0095719] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
9 De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis. 2011;3:e2011063. [PMID: 22220260 DOI: 10.4084/mjhid.2011.063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
10 Amiral J, Vissac AM, Seghatchian J. Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay. Transfus Apher Sci 2017;56:906-13. [PMID: 29162399 DOI: 10.1016/j.transci.2017.11.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Oluwaseyi BE, Michael OA, Oluwafemi AE, David AB. Pregnancy associated coagulopathies in selected community hospitals in Southwest Nigeria. J Family Med Prim Care 2021;10:1614-20. [PMID: 34123901 DOI: 10.4103/jfmpc.jfmpc_1381_20] [Reference Citation Analysis]
12 Vishwajeet V, Jamwal M, Sharma P, Das R, Ahluwalia J, Dogra RK, Rohit MK. Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons. Acta Cardiol 2018;73:328-34. [PMID: 28978253 DOI: 10.1080/00015385.2017.1384172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]